Tower Research Capital LLC (TRC) - ELEDON PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of ELEDON PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$11,567
-26.3%
8,443
-26.3%
0.00%
-100.0%
Q2 2023$15,687
+104480.0%
11,450
+83.2%
0.00%
Q1 2023$15
+275.0%
6,251
+229.3%
0.00%
Q4 2022$4
-99.6%
1,898
+196.6%
0.00%
Q3 2022$1,000
-66.7%
640
-38.2%
0.00%
Q2 2022$3,000
-40.0%
1,035
-21.9%
0.00%
Q1 2022$5,000
-44.4%
1,326
-35.5%
0.00%
Q4 2021$9,000
+80.0%
2,056
+219.8%
0.00%
Q2 2021$5,0006430.00%
Other shareholders
ELEDON PHARMACEUTICALS INC shareholders Q4 2023
NameSharesValueWeighting ↓
CM Management, LLC 225,000$549,0000.58%
BVF INC/IL 2,326,710$5,677,0000.27%
Cormorant Asset Management, LP 1,305,095$3,184,0000.24%
Ikarian Capital, LLC 362,537$884,0000.16%
JMAC ENTERPRISES LLC 54,538$133,0000.03%
Woodline Partners LP 516,675$1,261,0000.02%
Eversept Partners, LP 59,065$144,1190.01%
INGALLS & SNYDER LLC 51,149$125,0000.01%
Point72 Asset Management, L.P. 428,360$1,045,0000.00%
BAILARD, INC. 27,413$67,0000.00%
View complete list of ELEDON PHARMACEUTICALS INC shareholders